It has been proposed that CD2, which is highly expressed on T cells, serves
to enhance T cell-antigen presenting cell (APC) adhesion and costimulate T
cell activation. Here we analyzed the role of CD2 using CD2-deficient mice
crossed with transgenic mice expressing a T cell receptor specific for lym
phocytic choriomeningitis virus (LCMV)-derived peptide p33. We found that a
bsence of CD2 on T cells shifted the p33-specific dose-response curve in vi
tro by a factor of 3-10. In comparison, stimulation of T cells in the absen
ce of lymphocyte function-associated antigen (LFA)-1-intercellular adhesion
molecule (ICAM)-1 interaction shifted the dose-response curve by a factor
of 10, whereas absence of both CD2-CD48 and LFA-1-ICAM-1 interactions shift
ed the response by a factor of similar to 100. This indicates that CD2 and
LFA-1 facilitate T cell activation additively. T cell activation at low ant
igen density was blocked at its very first steps, as T cell APC conjugate f
ormation, TCR triggering, and Ca2+ fluxes were affected by the absence of C
D2. In vivo, LCMV-specific, CD2-deficient T cells proliferated normally upo
n infection with live virus but responded in a reduced fashion upon cross-p
riming. Thus, CD2 sets quantitative thresholds and fine-tunes T cell activa
tion both ill vitro and in vivo.